World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
51
Citations
13572
World Ranking
4120
National Ranking
43

Xia Jin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Xia Jin sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 164 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Xia Jin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Xia Jin sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Xia Jin is affiliated with the Chinese Academy of Sciences in China and has contributed extensively to research in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans multiple subfields including Infectious Diseases, Molecular Biology, Public Health, Environmental and Occupational Health, Immunology, and Epidemiology.

Among their recent publications are studies focusing mostly on viral infections and immune response mechanisms. Notable papers include:

  • "A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2" (2020, International Journal of Molecular Sciences)
  • "Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2" (2020, Virologica Sinica)
  • "Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults" (2021, Communications Biology)
  • "Vaccines and Therapeutics Against Hantaviruses" (2020, Frontiers in Microbiology)
  • "Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in Mice" (2020, Molecular Therapy - Methods & Clinical Development)

Their research covers main topics such as:

  • Mosquito-borne diseases and control
  • Viral Infections and Vectors
  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • COVID-19 Clinical Research Studies
  • Biosensors and Analytical Detection
  • Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities

Xia Jin collaborates frequently with a number of researchers. Their most common coauthors include:

  • Chiyu Zhang
  • Jiangyan He
  • Zhenzhou Wan
  • Qiyong Lou
  • Zhan Yin

Their work has been published often in the following journals and venues:

  • Virologica Sinica
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccine
  • Frontiers in Endocrinology
  • International Journal of Molecular Sciences

Best Publications

  • Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

    G. S. Ogg;Xia Jin;S. Bonhoeffer;P. R. Dunbar

  • Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques

    Xia Jin;Daniel E. Bauer;Sarah E. Tuttleton;Sharon Lewin

  • The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

    M. R. Wills;A. J. Carmichael;K. Mynard;X. Jin

  • Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.

    A. Carmichael;Xia Jin;P. Sissons;L. Borysiewicz

  • Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy

    G S Ogg;X Jin;S Bonhoeffer;P Moss

  • Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy.

    Linqi Zhang;Sharon R. Lewin;Martin Markowitz;Hsi-Hsun Lin

  • HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

    Gabriel M. Ortiz;Douglas F. Nixon;Alexandra Trkola;James Binley

  • Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells

    Zhihua Kou;Matthew Quinn;Huiyuan Chen;W W Shanaka I Rodrigo

  • A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2.

    Renfei Lu;Xiuming Wu;Zhenzhou Wan;Yingxue Li

  • A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals

    Marie Larsson;Xia Jin;Bharat Ramratnam;Graham S. Ogg

  • Simulation and Prediction of the Adaptive Immune Response to Influenza A Virus Infection

    Ha Youn Lee;David J. Topham;Sung Yong Park;Joseph Hollenbaugh

  • Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy

    Linqi Zhang;Chris Chung;Bor-Shen Hu;Tian He

  • Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

    Karin J. Metzner;Xia Jin;Fred V. Lee;Agegnehu Gettie

  • Development of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2.

    Renfei Lu;Xiuming Wu;Zhenzhou Wan;Yingxue Li

  • APOBEC3G/CEM15 (hA3G) mRNA Levels Associate Inversely with Human Immunodeficiency Virus Viremia

    Xia Jin;Andy Brooks;Huiyuan Chen;Ryan Bennett

  • Differential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human FcγRIA (CD64) or FcγRIIA (CD32)

    W. W. Shanaka I. Rodrigo;Xia Jin;Shanley D. Blackley;Robert C. Rose

  • In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations.

    Yi Yang;Weilai Sun;Jingjing Guo;Guangyu Zhao

  • Primary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In Vitro

    Shanley Blackley;Zhihua Kou;Huiyuan Chen;Matthew Quinn

  • Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination

    Martin Markowitz;Xia Jin;Arlene Hurley;Viviana Simon

  • Long noncoding RNA MALAT1 releases epigenetic silencing of HIV-1 replication by displacing the polycomb repressive complex 2 from binding to the LTR promoter.

    Di Qu;Wei-Wei Sun;Li Li;Li Ma

Frequent Co-Authors

David D. Ho
David D. Ho Columbia University
Douglas F. Nixon
Douglas F. Nixon Cornell University
Hulin Wu
Hulin Wu The University of Texas Health Science Center at Houston
Michael C. Keefer
Michael C. Keefer University of Rochester
Yunzhen Cao
Yunzhen Cao Beijing YouAn Hospital
Agegnehu Gettie
Agegnehu Gettie Aaron Diamond AIDS Research Center
Alan S. Perelson
Alan S. Perelson Los Alamos National Laboratory
Martin Markowitz
Martin Markowitz Rockefeller University
Lishan Su
Lishan Su University of Maryland, Baltimore
Linqi Zhang
Linqi Zhang Tsinghua University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology opens doors to diverse healthcare and research careers, often requiring tailored educational pathways. Many students interested in clinical practice consider programs that accelerate their journey into nursing and specialized roles. For example, enrolling in accelerated FNP programs can fast-track becoming a Family Nurse Practitioner, a role that integrates immunology knowledge in patient care.

For individuals without nursing backgrounds, exploring online ADN programs for non nurses offers accessible entry points into nursing, where foundational immunology concepts are applied clinically. Additionally, those seeking quicker admissions might benefit from researching the easiest accelerated nursing programs, which provide streamlined curricula to build essential skills efficiently.

Entry-level nursing roles, such as Licensed Practical Nurse (LPN), also integrate essential immunology principles in patient care. Students looking for flexible and attainable options can find guidance on which LPN programs are easiest to get into, allowing them to begin their healthcare careers while continuing education in fields related to immunology.

Best Scientists Citing Xia Jin

Trending Scientists

Recently Published Articles